Efficiency integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer and an activating EGFR gene mutation. Вопр. онкол. [Internet]. 2022 May 6 [cited 2026 Oct. 14];67(2):246-53. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/651